Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: GeneNews; Accelr8; Atlas Antibodies, Gene Company

NEW YORK (GenomeWeb News) – GeneNews' shares began trading this week the Toronto Stock Exchange on a one-for-six consolidated basis, resultin in 33,744,883 issued and outstanding shares. The consolidation was previously announced on Dec. 7 and was approved by the company's shareholders in April.


Accelr8 Technology began trading on the Nasdaq on Wednesday after moving from the New York Stock Exchange. Its stock trades under the ticker symbol "AXDX," and on its website the company has also begun calling itself Accelerate Diagnostics.


Atlas Antibodies has chosen Hong Kong-based firm Gene Company to distribute its polyclonal and monoclonal antibodies for research use in China, Hong Kong, and Macau.


In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.